← Leaderboards
Thomas K Karikari
Wake Forest University Health Sciences
$14,806,588
Attributed
$18,911,062
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.7M · FY2023–25$10M$7.5M$5M$2.5M$0
'23
'24
'25
Funding mix
By agency
NIH$18,911,062 · 3
By mechanism
R01$12,972,426 · 1
U24$5,472,632 · 1
P30$466,004 · 1
Top collaborators
- Nicole R. Fowler3 shared
- Michelle M Mielke3 shared
- Jeff Douglas Williamson3 shared
Most similar at Wake Forest University Health Sciences
Same institution · by research overlap
- Jeff Douglas Williamson$16,761,474
- Benjamin A Rowland$2,861,101
- Barry E Stein$16,613,647
- Chinedu Theresa Udeh-Momoh$2,161,741
- Mark Andrew Espeland$64,414,527
Others in their field
Other Rising Stars on “Alzheimer&Apos”
- Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
- Yanling Wang · Rush University Medical Center$2,986,919
- William G Mantyh · University Of Minnesota$2,961,521
- Allison Mercedes Caban-Holt · University Of Miami School Of Medicine$2,611,182
- Brian Stephen Appleby · Cleveland Clinic Lerner Com-Cwru$2,482,260
- Noah Ray Johnson · University Of Colorado Denver$2,282,487
Research focus
Alzheimer&AposNeuropathologyS Disease Related DementiaCostPathologyTau-1Amyloid Beta-ProteinLightBloodPerformanceTau ProteinsAmyloidBiological MarkersNeurofilamentEthnic OriginCaringDiagnostic AccuracyS Disease DiagnosisRaceS Disease PathologyCohortDiagnosisAffectNerve Degeneration
Grant awards (7)
Alzheimer Diagnosis in older Adults with Chronic Conditions ADACC Network$1,787,678
U24 · FY2025 · AG
Plasma brain-derived tau: a novel Alzheimerâs disease-type neurodegeneration biomarker with potential to complete the AT(N) scheme in blood$1,483,998
R01 · FY2025 · AG · contact PI
Biomarker and Neurogenetics Core$466,004
P30 · FY2025 · AG · contact PI
Plasma brain-derived tau: a novel Alzheimerâs disease-type neurodegeneration biomarker with potential to complete the AT(N) scheme in blood$5,693,957
R01 · FY2024 · AG · contact PI
Alzheimer Diagnosis in older Adults with Chronic Conditions ADACC Network$1,800,259
U24 · FY2024 · AG
Plasma brain-derived tau: a novel Alzheimerâs disease-type neurodegeneration biomarker with potential to complete the AT(N) scheme in blood$5,794,471
R01 · FY2023 · AG · contact PI
Alzheimer Diagnosis in older Adults with Chronic Conditions ADACC Network$1,884,695
U24 · FY2023 · AG